Skip to content

Asimov vs Profluent

Asimov logo

Asimov

Intelligent design of living systems

120 employees · est. 2017 · Boston, United States

VS
Profluent logo

Profluent

Grounded in nature, authored by AI

83 employees · est. 2022 · Emeryville, United States

Asimov is the older company (2017 vs 2022).

Side-by-Side Comparison

Asimov Profluent
Founded
2017 older 2022
Headquarters
Boston, United States Emeryville, United States
Employees
120 83
Industry
AI, Biotechnology, Health and Wellness AI, Biotechnology
Funding Stage
Series B Venture round
Total Funding
$204.70M $44.00M
Funding Rounds
4 2
Services
end-to-end genetic design platform, cell line development, gene and RNA therapy production, biological tools and computational models, lab-in-the-loop platform, design and manufacturing integration AI-authored Protein Solutions, CRISPR Gene Editing, Custom Protein Design, Biological Research and Development
Target Customers
biotech companies, pharmaceutical companies, synthetic biologists, research institutions, healthcare innovators, biotherapeutics developers Pharmaceutical Companies, Agricultural Biotechnology Firms, Industrial Biotech Manufacturers, Research Institutions
Taxonomy
Intelligent DesignLiving SystemsSynthetic BiologyMammalian BiologyComputer-Aided DesignBiologics Manufacturing +6 AI-first Protein DesignDeep Generative ModelsNovel ProteinsBiomedicine RevolutionFunctional Protein DesignProtein Validation +9
Website
asimov.com profluent.bio
Asimov logo

About Asimov

Asimov is at the forefront of bioengineering, propelling the AI, Biotechnology, and Health and Wellness industries with its innovative approach to cellular programming. Founded in 2017, the company harnesses the synergies of mammalian synthetic biology, computer-aided design, and machine learning. T...

Profluent logo

About Profluent

Profluent, a pioneering player in the intersection of AI and biotechnology, is making significant strides in revolutionizing protein design. Established in 2022, the company is based in Emeryville, CA, and has garnered support from top-tier investors including Spark Capital, Insight Partners, Air St...

Also comparing in this category

Comparing more than these two?

Get Asimov, Profluent and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Asimov compare?

A PDF of Asimov and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Asimov was founded in 2017, based in Boston, United States, with 120 employees. Asimov is at the forefront of bioengineering, propelling the AI, Biotechnology, and Health and Wellness industries with its innovative approach to cellular programming. Founded in 2017, the company ha. Profluent was founded in 2022, based in Emeryville, United States, with 83 employees. Profluent, a pioneering player in the intersection of AI and biotechnology, is making significant strides in revolutionizing protein design. Established in 2022, the company is based in Emeryville, CA.
Asimov has raised $204.70M and Profluent $44.00M. Latest stage: Asimov Series B, Profluent Venture round.
Both work in AI and Biotechnology and list synthetic biology, biotech innovation and life sciences among their focus areas.

Compare Asimov with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Asimov on 8 Nov 2026, and Profluent on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout